Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy
…, F Magri, G Menozzi, C Bonaglia, F Rizzo… - Science translational …, 2012 - science.org
Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases
that cause infant mortality. Induced pluripotent stem cells (iPSCs) generated from skin …
that cause infant mortality. Induced pluripotent stem cells (iPSCs) generated from skin …
[HTML][HTML] Direct reprogramming of human astrocytes into neural stem cells and neurons
…, M Falcone, C Donadoni, S Salani, F Rizzo… - Experimental cell …, 2012 - Elsevier
Generating neural stem cells and neurons from reprogrammed human astrocytes is a
potential strategy for neurological repair. Here we show dedifferentiation of human cortical …
potential strategy for neurological repair. Here we show dedifferentiation of human cortical …
Neural stem cell transplantation for neurodegenerative diseases
R De Gioia, F Biella, G Citterio, F Rizzo, E Abati… - International journal of …, 2020 - mdpi.com
Neurodegenerative diseases are disabling and fatal neurological disorders that currently lack
effective treatment. Neural stem cell (NSC) transplantation has been studied as a potential …
effective treatment. Neural stem cell (NSC) transplantation has been studied as a potential …
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives
G Stuppia, F Rizzo, G Riboldi, R Del Bo… - Journal of the …, 2015 - Elsevier
Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane,
encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of …
encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of …
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis …
M Nizzardo, C Simone, F Rizzo… - Human molecular …, 2014 - academic.oup.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease characterized by the
degeneration of motor neurons. Currently, there is no effective therapy for ALS. Stem cell …
degeneration of motor neurons. Currently, there is no effective therapy for ALS. Stem cell …
[HTML][HTML] Mitochondrial fusion proteins and human diseases
…, S Brajkovic, G Riboldi, D Ronchi, F Rizzo… - Neurology research …, 2013 - hindawi.com
Mitochondria are highly dynamic, complex organelles that continuously alter their shape,
ranging between two opposite processes, fission and fusion, in response to several stimuli and …
ranging between two opposite processes, fission and fusion, in response to several stimuli and …
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
F Rizzo, G Riboldi, S Salani, M Nizzardo… - Cellular and Molecular …, 2014 - Springer
Neurodegenerative disorders are characterized by the selective vulnerability and progressive
loss of discrete neuronal populations. Non-neuronal cells appear to significantly contribute …
loss of discrete neuronal populations. Non-neuronal cells appear to significantly contribute …
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
S Salani, C Donadoni, F Rizzo… - Journal of cellular …, 2012 - Wiley Online Library
• Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell
induction from ESCs ‐ The first method: generation of MMPs from ESCs and their differentiation …
induction from ESCs ‐ The first method: generation of MMPs from ESCs and their differentiation …
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons
F Rizzo, D Ronchi, S Salani, M Nizzardo… - Human molecular …, 2016 - academic.oup.com
Charcot-Marie-Tooth 2A (CMT2A) is an inherited peripheral neuropathy caused by mutations
in MFN2, which encodes a mitochondrial membrane protein involved in mitochondrial …
in MFN2, which encodes a mitochondrial membrane protein involved in mitochondrial …
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
M Nizzardo, C Simone, F Rizzo, S Salani, S Dametti… - Science …, 2015 - science.org
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an autosomal recessive
motor neuron disease affecting children. It is caused by mutations in the IGHMBP2 gene (…
motor neuron disease affecting children. It is caused by mutations in the IGHMBP2 gene (…